Board to Initiate CEO Search Process; Scott Hirsch Appointed as Interim CEO MALVERN, Pa., Aug. 27, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) (“Endo” or the “Company”), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced…